Structure:function studies of the glucocorticoid receptor

结构：糖皮质激素受体的功能研究

• 批准号: 7252033
• 负责人: RAJ KUMAR
• 金额: $ 8.42万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-02-15 至 2009-07-06
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7252033
• 关键词: 3-Dimensional; AF2; Acidic Amino Acids; Adopted; Amino Acid Sequence; Amino Acids; Basic Science; Binding; Biological Assay; C-terminal; CREB-binding protein; Chemicals; Circular Dichroism; Clinical; Collaborations; Communication; Complex; Condition; Crystallization; DNA; DNA Binding Domain; Data; Deuterium; Developmental Process; Employee Strikes; Enhancers; Family; Figs - dietary; Fluorescence; Fluorescence Resonance Energy Transfer; Fourier Transform; Funding; Future; Gene Activation; Gene Expression; Gene Targeting; Genes; Genetic Transcription; Glucocorticoid Receptor; Glucocorticoids; Goals; Grant; In Vitro; Incubated; Knowledge; Laboratories; Left; Letters; Ligands; Mammalian Cell; Mass Spectrum Analysis; Modeling; Molecular; Molecular Chaperones; Molecular Conformation; Monitor; N-terminal; NMR Spectroscopy; Nuclear Hormone Receptors; Numbers; Peptides; Physiological; Play; Positioning Attribute; Process; Protein Binding; Protein Footprinting; Proteins; Proteolysis; Proteomics; Publishing; Recombinants; Regulation; Research Institute; Research Personnel; Resolution; Response Elements; Role; Signal Transduction; Solutions; Steroid Receptors; Steroids; Structure; Surface; TATA-Box Binding Protein; Techniques; Testing; Therapeutic; Thyroid Hormones; Time; Transactivation; Transcriptional Activation; Tretinoin; Work; base; cell type; chromatin immunoprecipitation; cofactor; conformer; drug discovery; experience; human CREBBP protein; human TAF1 protein; in vivo; innovation; insight; intermolecular interaction; member; mutant; nuclear receptor coactivator 1; promoter; three dimensional structure; transcription factor

DESCRIPTION (provided by applicant): The long-term goal of this ongoing grant is to understand the relationship between structure and function of the glucocorticoid receptor (GR). The precise mechanism by which the GR controls regulation of specific genes is not known. This is in part due to lack of knowledge of the functional structure of GR's N-terminal activation function domain AF. Until recently, it was difficult to determine AF1 structure because in solution it exists as a random ensemble of conformers. Our findings under this ongoing grant have for the first time given an opportunity to determine functional folded AF1 structure. Using a variety of biophysical/proteomics techniques, we have shown that: i) naturally occurring osmolytes can induce structure in recombinant AF1; and ii) AF1 acquires folded structure through inter-domain signaling when the DMA-binding domain binds to its cognate glucocorticoid response element. Under in vitro conditions, this folded form of AF1 selectively binds specific coregulatory proteins, known to be important for GR's action. We therefore believe that this induced conformation in AF1 is functional. However, as for all the steroid receptors, the 3-D structure of the GR AF1 is lacking. Also unknown is whether in the holo-GR the AF1 domain is still unstructured. Based on our published and new preliminary results, we hypothesize that under physiological conditions, AF1 acquires partial or fully folded conformation due to its direct interaction with other cofactor protein(s), and/or intra-molecular signals passed by ligand/GRE binding. During the next funding period of this grant, we will: 1) test the effects of interactions of specific coregulatory protein(s) on the structure of AF1; 2) determine the 3-D structure of the GR AF1 domain under conditions that fold it into a functionally active form; 3) examine the structure of AF1 in the holo-GR; 4) test the effect of AF1 folding on its interaction with other coregulatory proteins under in vivo conditions. Successfully completing our Specific Aims will not only provide pivotal knowledge on the structure and functions of AF1, but will also give important new general insights into how the GR--and related transcription factors--transmit the transcriptional signal from ligand to specific target gene(s).

描述（由申请人提供）：这项正在进行的资助的长期目标是了解糖皮质激素受体（GR）的结构和功能之间的关系。GR控制特定基因调节的精确机制尚不清楚。这在一定程度上是由于缺乏知识的GR的N-末端激活功能域AF的功能结构。直到最近，它是难以确定AF 1的结构，因为在解决方案中，它存在的构象随机合奏。我们在这项正在进行的资助下的研究结果首次提供了确定功能性折叠AF 1结构的机会。使用各种生物物理/蛋白质组学技术，我们已经表明：i）天然存在的渗透剂可以诱导重组AF 1中的结构;和ii）当DMA结合结构域结合其同源糖皮质激素反应元件时，AF 1通过结构域间信号传导获得折叠结构。在体外条件下，这种折叠形式的AF 1选择性地结合特定的辅助调节蛋白，已知对GR的作用很重要。因此，我们认为，这种诱导的构象在AF 1是功能性的。然而，对于所有的类固醇受体，GR AF 1的三维结构是缺乏的。同样未知的是，在全息GR中，AF 1结构域是否仍然是非结构化的。基于我们发表的和新的初步结果，我们假设在生理条件下，AF 1获得部分或完全折叠构象，由于其与其他辅因子蛋白的直接相互作用，和/或通过配体/GRE结合传递的分子内信号。在该基金的下一个资助期内，我们将：1）测试特定共调节蛋白相互作用对AF 1结构的影响; 2）确定GR AF 1结构域在折叠成功能活性形式的条件下的三维结构; 3）检查AF 1在全息GR中的结构; 4）在体内条件下测试AF 1折叠对其与其他共调节蛋白相互作用的影响。成功完成我们的特定目标不仅将提供关于AF 1的结构和功能的关键知识，而且还将对GR-和相关转录因子-如何将转录信号从配体传递到特定靶基因提供重要的新的一般见解。